TY  - GEN
AU  - El-Hammadi, Mazen M.
AU  - Arias, Jose L.
PY  - 2022
DO  - 10.3390/nano12030354
UR  - http://hdl.handle.net/10668/21442
T2  - Nanomaterials
AB  - Therapeutics are habitually characterized by short plasma half-lives and little affinity for targeted cells. To overcome these challenges, nanoparticulate systems have entered into the disease arena. Poly( D,L-lactide-co-glycolide) (PLGA) is one of...
LA  - en
PB  - MDPI AG
KW  - active drug targeting
KW  - ligand-mediated targeting
KW  - nanoparticle
KW  - passive drug targeting
KW  - PLGA
KW  - stealth coating
KW  - surface functionalization
KW  - Poly(lactic-co-glycolic acid) nanoparticles
KW  - Cell-penetrating peptides
KW  - Drug-delivery
KW  - In-vitro
KW  - Polymeric nanoparticles
KW  - Poly(ethylene glycol)
KW  - Polyethylene-glycol
KW  - Mediated delivery
KW  - Peg nanoparticles
KW  - Targeted delivery
KW  - Surface-Active Agents
KW  - Biocompatible Materials
KW  - Nanomedicine
KW  - dilactide
KW  - Polymers
KW  - Nanoparticles
KW  - Colloids
KW  - Chemistry, Physical
KW  - Lipids
TI  - Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
TY  - review
VL  - 12
ER  -